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INTRODUCTION:
Histiocytic sarcoma is a rare, lympho-hematopoietic 
malignant neoplasm composed of mature tissue 
histiocytes. It can occur at any age, from infancy to 
adulthood.The most frequently involved organs are 
the skin, lymph nodes, and intestinal tract. 
Involvement of the central nervous system (CNS) as 
either a part of a systemic disease or as a primary 
lesion has rarely been described so far1. We present 
the imaging features and manifestations of Biopsy 
proven Histiocytic Sarcoma of the Falxcerebri in this 
case.
CASE REPORT:
A 22 year old male presented to the Civil Hospital in 
June 2016 with symptoms of chronic headache and 
bilateral lower limb weakness for last 1 month.There 
were no known co-morbids. There was hypertonia 
with positive babinski sign and power was 3/5 on 
average in all muscle compartmentsof lower limbs.
Magnetic resonance imaging of the Brain was 
performed on GE Health Care SignaHDxt 1.5 Tesla 
Scanner which revealed11x7cmaggressive 
heterogeneously enhancing extra-axial anterior falx 
mass with extensive peri-lesionalvasogenic edema 
(Fig.1). The initial differentials aroused in this patient 
w e r e  a g g r e s s i v e  f a l x  m e n i n g i o m a  / 
haemangiopericytoma.Before planning for the 
management, the patient was lost on follow up and 
presented again in September 2016 with worsening 
of the symptoms and new onset of seizures.The 
patient then underwent Contrast CT Brain(Fig.2) 
performed with 16 slice ToshibaSpiral CT Scanner 
which re-demonstrated the lesion with signiﬁcant size 
increment and duralsino-venous thrombosis 
involving the superior sagittal sinus, trans-calvarial 
and scalp invasion.
The surgical resection of the tumor and craniectomy 
was done.Thehisto-pathological specimen examined 
at AKUH showed multiple irregular tan white irregular 
soft tissue fragments. Its microscopic sections 
revealed  neoplastic cells arranged in sheets and 
nodules. The neoplastic cells are large, show 
abundant eosinophilia cytoplasm, pleomorphic, 
vesicular nuclei with variably prominent nucleoli. 
Multinucleated tumor cells also noted. Intervening 
areas show moderate to dense inﬂammation 
comprising of lymphocytes, plasma cells, neutrophils 
and eosinophil. Immuno-histochemical stains were 
performed which show that LCA is Positive & CD68 
and S-100 are diffuse strong positive in the neoplastic 
cells. The biopsy features were consistent with  
Histiocytic Sarcoma.He later on developed severe 
malaise, cachexia, altered level of consciousness. 
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DISCUSSION:
Histiocytic sarcoma (HS) is a rare neoplasm 
composed of tumor cells derived from the 
monocyte/macrophage lineage. HS has been 
reported in associat ion wi th a number of 
hematological malignancies, including Acute 
Lymphoblastic Leukemia (ALL) 2. Chalasani S. et al 
reported a case of 44 years old male, presented with 
unsteadiness, loss of balance, and left-sided 
weakness of 2 weeks2. He underwent CT and MRI 
scan of the brain that showed two intra-axial 
enhancing lesions: one in the corpus callosum of 3.5 
cm, and the other adjacent to the right lateral ventricle 
of 2.6 cm, both associated with vasogenic edema. His 
previous history revealed that he had been diagnosed 
with ALL with cerebrospinal ﬂuid (CSF) involvement 
16 years prior. 
The interim CT scan performed in February 
2017showed no recurrence with post-operative 
s u b d u r a l  c o l l e c t i o n m e a s u r i n g  1 . 7 c m  i n 
depth(Fig.3),extending into falx under the 6.0x5.5cm 
post-surgical parietal defect; the liverwas enlarged in 
size measuring 19.2cm with multiple hypodense 
lesions seen in both lobes of the liver, largest 
measuring 1.5x1.0cm in segment VIII of liver; in 
keeping with distant hepatic metastases (Fig.4). The 
patient was referred to Oncology for induction of 
chemotherapy.
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Figure 1: 
Coronal MRI Brain Contrast showingFalx lesion 
with peri-lesional edema(arrow)
Figure 2: 
Coronal CT Brain showing trans-calvarial 
invasion of the Dural tumor.
Figure 3: 
Sagittal CT Brain showing subdural collection
Figure 4: 
Axial Contrast CT Abdomen showing liver 
metastases (white arrows)
rare and is usually aggressive. Its rarity can easily 
lead to  a  misd iagnosis .Bra in  b iopsy wi th 
immunophenotypic study is the only way to conﬁrm 
the diagnosis and should not be delayed. To the best 
of authors' knowledge, the extra-axial CNS histiocytic 
Sarcoma involving FalxCerebri has not been 
described earlier in the literature. 
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Diagnosis of HS requires the presence of histiocytic 
markers and the systematic exclusion of markers of 
other cell lineages. Primary HS central nervous 
system tumors are aggressive and generally have 
poor outcomes.
So H and his colleagues3 in 2015 described a patient 
with primary CNS histocytic sarcoma involving the 
cerebral hemisphere and spinal cord, who had been 
initially misdiagnosed as demyelinating disease. Two 
biopsies were necessary before a correct diagnosis 
was made. A histologic examination showed bizarre 
shaped histiocytes with larger nuclei and nuclear 
atypia. The cells were positive for CD68, CD163, and 
S-100 protein.
In 2013, Pérez-Ruiz E et al4 presented case of 41-
year-old Caucasian woman with no previous history 
of disease who started with systemic symptoms such 
as headache and chills. Magnetic resonance imaging 
with gadolinium contrast of the brain suggested a 
1.5×2cm meningeal mass in the temporal lobe with a 
non-uniform vasogenic edema. The histological 
ﬁndings revealed a histiocytic sarcoma- comparable 
to our case, however our case showed the site of 
tumor at falx.
Devic P et al5reported a case of 43-year-old patient in 
the International Journal of Medicinewho had 
complains of progressive ataxia, headache and 
altered general status lasting for 3 weeks. Brain 
magnetic resonance imaging (MRI) showed 
T2hyperintense multifocal lesions involvingcorpus 
callosum, right middle cerebellar peduncle, right 
periventricular white matter, cervical and dorsal 
spinal cord with homogeneous gadol inium 
enhancement in T1 post contrast sequence.
CNS histiocytic sarcoma is an extremely rare and 
severe disease and should be suspected when facing 
rapidly evolving neurological manifestations6. There 
is no consensus on the most appropriate treatment 
because of the lack of data and limited number of 
reported cases.
CONCLUSION:
Involvement of the central nervous system in HS is  
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